Skip to main content

Table 4 Low-risk and high-risk HPV infections in the vagina and the uterine cervix n (%)

From: High Concordance between Vaginal Samples and Cervical Samples of Human Papillomavirus in Women Living with HIV in Rwanda

HPV Infections (Ct < 37)

Cervix HPV n (%)

Vagina HPV n (%)

Sum (% of all infections)

Concordance (S.E.M)

HPV6

15 (5.6)

12 (4.4)

27 (5.0)

0.66 (0.11)

HPV11

6 (2.3)

7 (2.6)

13 (2.4)

0.77 (0.13)

HPV16

30 (11.3)

27 (9.9)

57 (10.6)

0.87 (0.04)

HPV18

20 (7.5)

19 (7.0)

39 (7.2)

0.81 (0.07)

HPV31

16 (6.0)

15 (5.5)

31 (5.8)

0.77 (0.09)

HPV33

14 (5.3)

14 (5.1)

28 (5.2)

0.93 (0.05)

HPV35

20 (7.5)

21 (7.7)

41 (7.6)

0.72 (0.08)

HPV39

12 (4.5)

14 (5.1)

26 (4.8)

0.76 (0.09)

HPV 45

12 (4.5)

13 (4.8)

25 (4.6)

0.88 (0.07)

HPV51

31 (11.7)

35 (12.9)

66 (12.3)

0.82 (0.06)

HPV52

33 (12.4)

34 (12.5)

67 (12.5)

0.82 (0.05)

HPV56

18 (6.8)

19 (7.0)

37 (6.9)

0.80 (0.07)

HPV58

36 (13.5)

39 (14.3)

75 (13.9)

0.87 (0.04)

HPV59

3 (1.1)

3 (1.1)

6 (1.1)

0.66 (0.22)

All types (Ct < 37)

266

272

538

0.82 (0.02)

HR-HPVs (Ct < 37)

245

253

498

0.83 (0.02)

All types (Ct < 40)

335

365

700

0.77 (0.02)

HR-HPVs (Ct < 40)

311

342

653

0.76 (0.02)

  1. Ct cycle threshold, HPV human papillomavirus, HR high-risk, S.E.M. standard error of the mean